203 related articles for article (PubMed ID: 17458558)
1. Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
Tawfik O; Kimler BF; Davis M; Stasik C; Lai SM; Mayo MS; Fan F; Donahue JK; Damjanov I; Thomas P; Connor C; Jewell WR; Smith H; Fabian CJ
Virchows Arch; 2007 Jun; 450(6):627-36. PubMed ID: 17458558
[TBL] [Abstract][Full Text] [Related]
2. A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.
Stevens E; Kimler BF; Davis MK; Fan F; Thomas P; Wang XY; Damjanov I; Tawfik OW
Ann Clin Lab Sci; 2009; 39(1):25-31. PubMed ID: 19201737
[TBL] [Abstract][Full Text] [Related]
3. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.
Chang JM; McCullough AE; Dueck AC; Kosiorek HE; Ocal IT; Lidner TK; Gray RJ; Wasif N; Northfelt DW; Anderson KS; Pockaj BA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S509-15. PubMed ID: 26001860
[TBL] [Abstract][Full Text] [Related]
4. Nuclear grade plus proliferation grading system for invasive ductal carcinoma of the breast: validation in a tertiary referral hospital cohort.
Papadimitriou M; Kaptanis S; Polymeropoulos E; Mitsopoulos G; Stogiannis D; Caroni C; Vaiopoulos G; Panayiotides JG; Karakitsos P
Am J Clin Pathol; 2015 Dec; 144(6):837-43. PubMed ID: 26572989
[TBL] [Abstract][Full Text] [Related]
5. Grading ductal carcinoma in situ of the breast using an automated proliferation index.
Stasik CJ; Davis M; Kimler BF; Fan F; Damjanov I; Thomas P; Tawfik OW
Ann Clin Lab Sci; 2011; 41(2):122-30. PubMed ID: 21844569
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.
Le Doussal V; Tubiana-Hulin M; Friedman S; Hacene K; Spyratos F; Brunet M
Cancer; 1989 Nov; 64(9):1914-21. PubMed ID: 2551477
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
8. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
[TBL] [Abstract][Full Text] [Related]
9. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
[TBL] [Abstract][Full Text] [Related]
11. Cellular proliferation in breast ductal infiltrating carcinoma. Correlation with clinical and histopathological variables.
Aranda FI; Laforga JB
Pathol Res Pract; 1997; 193(10):683-8. PubMed ID: 9505260
[TBL] [Abstract][Full Text] [Related]
12. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.
Genestie C; Zafrani B; Asselain B; Fourquet A; Rozan S; Validire P; Vincent-Salomon A; Sastre-Garau X
Anticancer Res; 1998; 18(1B):571-6. PubMed ID: 9568179
[TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.
Meyer JS; Alvarez C; Milikowski C; Olson N; Russo I; Russo J; Glass A; Zehnbauer BA; Lister K; Parwaresch R;
Mod Pathol; 2005 Aug; 18(8):1067-78. PubMed ID: 15920556
[TBL] [Abstract][Full Text] [Related]
16. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.
Frierson HF; Wolber RA; Berean KW; Franquemont DW; Gaffey MJ; Boyd JC; Wilbur DC
Am J Clin Pathol; 1995 Feb; 103(2):195-8. PubMed ID: 7856562
[TBL] [Abstract][Full Text] [Related]
17. Terminal uridine nick end labelling and mitosis in breast carcinoma. Correlation with tumor grade and p53 overexpression.
Dey P; Luthra UK; George SS; Haji BI; George J
Anal Quant Cytol Histol; 2001 Feb; 23(1):27-30. PubMed ID: 11233740
[TBL] [Abstract][Full Text] [Related]
18. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
19. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
20. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast.
Choi Y; Kim EJ; Seol H; Lee HE; Jang MJ; Kim SM; Kim JH; Kim SW; Choe G; Park SY
Hum Pathol; 2012 Jan; 43(1):48-55. PubMed ID: 21733550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
